The National Physician Survey of Precision Medicine in Cancer Treatment (NCI)

ICR 201605-0925-011

OMB: 0925-0739

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Form and Instruction
Unchanged
Justification for No Material/Nonsubstantive Change
2016-05-31
Justification for No Material/Nonsubstantive Change
2016-05-31
Supplementary Document
2016-02-26
Supplementary Document
2016-02-22
Supplementary Document
2016-02-22
Supplementary Document
2016-02-22
Supplementary Document
2016-02-22
Supplementary Document
2016-02-22
Supporting Statement B
2016-05-12
Supporting Statement A
2016-05-12
ICR Details
0925-0739 201605-0925-011
Historical Active 201602-0925-012
HHS/NIH
The National Physician Survey of Precision Medicine in Cancer Treatment (NCI)
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 06/03/2016
Retrieve Notice of Action (NOA) 06/03/2016
  Inventory as of this Action Requested Previously Approved
05/31/2018 05/31/2018 05/31/2018
2,190 0 2,190
350 0 350
0 0 0

The purpose of this study is to investigate the current practice of precision medicine in cancer treatment among medical oncologists in the U.S. This is a nationally representative survey designed to assess oncologists’ current and potential use of genomic testing, to inform the development of interventions to facilitate optimal use of genomic testing and to improve patient-physician discussions of the risks, possible benefits, and uncertainties surrounding the use of these tests. Current knowledge of this topic is limited as there are no nationally-representative studies on this topic to date.

US Code: 42 USC sect 285 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  80 FR 72077 11/18/2015
81 FR 9869 02/26/2016
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 2,190 2,190 0 0 0 0
Annual Time Burden (Hours) 350 350 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
This is a new submission.

$368,520
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Tawanda Abdelmouti 240 276-5530 ta401@nih.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
06/03/2016


© 2024 OMB.report | Privacy Policy